Monthly Archives: September 2018

Wilson Medicine Company Receives Warning Letter from FDA

The agency sent a warning letter to the Indian company after an inspection revealed violations of the CGMP, including a lack of written procedures and analytical testing. The FDA sent a warning letter to Wilson Medicine Company, as of September 11, 2018, after inspectors discovered violations of current good manufacturing …

Read More »